Tebipenem pivoxil (Utebzi) is an oral antibiotic used to treat specific complicated urinary tract infections.

I. Correct Administration and Dose Management

1. Take strictly on time and at the prescribed dose

(1) The recommended dose is 600 mg (two 300 mg tablets) every 6 hours for a course of 7 to 10 days.

(2) Set fixed dosing times to ensure even intervals, thereby maintaining stable drug concentrations in the blood.

(3) Do not extend the course on your own, as prolonged use may increase the risk of carnitine depletion.

2. Swallow whole; food effect is manageable

(1) Tablets should be swallowed whole with water and not chewed, crushed, or split, to avoid damaging the film coating that affects drug release characteristics.

(2) Tebipenem pivoxil can be taken with or without food; a high‑fat meal has no clinically significant effect on absorption, so patients may choose based on their routine.

3. Management of missed doses

(1) If you forget to take a dose, take it as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and take the next one on schedule.

(2) Never take a double dose to make up for a missed one, as this increases the risk of adverse reactions.

II. Contraindications to be clearly identified before use

1. Allergy history check

This product is contraindicated in patients with a history of hypersensitivity to carbapenems, penicillins, cephalosporins, or other beta‑lactam antibiotics.

2. Contraindicated in conditions related to carnitine deficiency

Patients with primary or secondary carnitine deficiency, as well as those with inborn errors of metabolism that may lead to clinically significant carnitine deficiency, must not use this drug.

3. Warnings for special populations

(1) Children: Safety and efficacy in patients under 18 years have not been established.

(2) Pregnant women: Use before delivery may cause false‑positive results in neonatal isovaleric acidemia screening.

(3) Nursing mothers: It is unknown whether the drug is excreted in human milk; the benefits of breastfeeding should be weighed against the potential risks.

III. Be aware of drug interactions and adverse reactions

1. Drugs that must be avoided

(1) Valproic acid / divalproex sodium: Absolutely contraindicated. Carbapenems significantly reduce valproic acid blood concentrations, potentially leading to breakthrough seizures.

(2) Probenecid and other OAT1/OAT3 inhibitors: Coadministration increases tebipenem blood levels, raising the risk of diarrhea, headache, and other adverse effects; concomitant use is generally not recommended.

2. Serious adverse reactions requiring close monitoring

(1) Central nervous system reactions: Patients with a history of seizures or brain lesions are at increased risk. If convulsions, tremor, confusion, or dizziness occur, stop the drug immediately and seek neurological evaluation.

(2) Severe allergic reactions: If breathing difficulty, laryngeal edema, generalized rash, or a drop in blood pressure occurs after taking the drug, stop immediately and seek emergency care.

(3) Symptoms of carnitine depletion: If hypoglycemia (dizziness, palpitations, hunger), muscle pain or weakness, severe fatigue, fainting, or confusion develop, prompt medical attention is required.

3. Danger signs in diarrhea

(1) Antibiotic‑associated diarrhea is common, but if frequent watery stools, bloody stools, abdominal cramps with fever occur, it may be a Clostridioides difficile infection and requires immediate medical evaluation.

(2) This infection can occur up to 2 months after drug discontinuation; do not take antidiarrheals on your own to mask the condition.

4. Reminder on antimicrobial resistance

(1) This product is indicated only for bacterial infections and is ineffective against viral illnesses such as the common cold.

(2) Even if symptoms improve, you must complete the full course; do not stop early or miss doses, as this reduces efficacy and induces bacterial resistance, making future infections harder to treat.